Management of hypertension in patients with mild to moderate aortic stenosis

Circulation

Volumn 134, Issue 6, 2016, Pages 469-471

  O'Gara, Patrick T ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

aortic valve stenosis; Editorials; hypertension

Indexed keywords

ACUTE CORONARY SYNDROME; AORTA STENOSIS; AORTA VALVE STENOSIS; CORONARY ARTERY BLOOD FLOW; CORONARY FLOW RESERVE; DIASTOLIC BLOOD PRESSURE; EDITORIAL; HEART FAILURE; HEART MUSCLE OXYGEN CONSUMPTION; HUMAN; HYPERTENSION; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE; VALVULAR HEART DISEASE; AORTIC VALVE; AORTIC VALVE STENOSIS; HEART VALVE REPLACEMENT; SEA;

AORTIC VALVE; AORTIC VALVE STENOSIS; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; HYPERTENSION; OCEANS AND SEAS;

EID: 85000786912     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.116.023688     Document Type: Editorial

References (16)

1. Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Böhm M, Christiaens T, Cifkova R, De Backer G, Dominiczak A, Galderisi M, Grobbee DE, Jaarsma T, Kirchhof P, Kjeldsen SE, Laurent S, Manolis AJ, Nilsson PM, Ruilope LM, Schmieder RE, Sirnes PA, Sleight P, Viigimaa M, Waeber B, Zannad F, Redon J, Dominiczak A, Narkiewicz K, Nilsson PM, Burnier M, Viigimaa M, Ambrosioni E, Caufield M, Coca A, Olsen MH, Schmieder RE, Tsioufis C, van de Borne P, Zamorano JL, Achenbach S, Baumgartner H, Bax JJ, Bueno H, Dean V, Deaton C, Erol C, Fagard R, Ferrari R, Hasdai D, Hoes AW, Kirchhof P, Knuuti J, Kolh P, Lancellotti P, Linhart A, Nihoyannopoulos P, Piepoli MF, Ponikowski P, Sirnes PA, Tamargo JL, Tendera M, Torbicki A, Wijns W, Windecker S, Clement DL, Coca A, Gillebert TC, Tendera M, Rosei EA, Ambrosioni E, Anker SD, Bauersachs J, Hitij JB, Caulfield M, De Buyzere M, De Geest S, Derumeaux GA, Erdine S, Farsang C, Funck-Brentano C, Gerc V, Germano G, Gielen S, Haller H, Hoes AW, Jordan J, Kahan T, Komajda M, Lovic D, Mahrholdt H, Olsen MH, Ostergren J, Parati G, Perk J, Polonia J, Popescu BA, Reiner Z, Rydén L, Sirenko Y, Stanton A, Struijker-Boudier H, Tsioufis C, van de Borne P, Vlachopoulos C, Volpe M, Wood DA, 2013 ESH/ESC guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH), and the European Society of Cardiology (ESC). Eur Heart J. 2013; 34: 2159-2219.
2. James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C, Handler J, Lackland DT, LeFevre ML, MacKenzie TD, Ogedegbe O, Smith SC Jr, Svetkey LP, Taler SJ, Townsend RR, Wright JT Jr, Narva AS, Ortiz E. 2014 Evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014; 311: 507-520. doi: 10.1001/.jama.2013.284427.
3. Sprint Research Group. A randomized trial of intensive versus standard blood-pressure control. N Engl J Med 2015; 373: 2103-2116.
4. Lonn EM, Bosch J, López-Jaramillo P, Zhu J, Liu L, Pais P, Diaz R, Xavier D, Sliwa K, Dans A, Avezum A, Piegas LS, Keltai K, Keltai M, Chazova I, Peters RJ, Held C, Yusoff K, Lewis BS, Jansky P, Parkhomenko A, Khunti K, Toff WD, Reid CM, Varigos J, Leiter LA, Molina DI, McKelvie R, Pogue J, Wilkinson J, Jung H, Dagenais G, Yusuf S. HOPE-3 Investigators. Blood-pressure lowering in intermediate-risk persons without cardiovascular disease. N Engl J Med. 2016; 374: 2009-2020. doi: 10.1056/NEJMoa1600175.
5. Xie X, Atkins E, Lv J, Bennett A, Neal B, Ninomiya T, Woodward M, MacMahon S, Turnbull F, Hillis GS, Chalmers J, Mant J, Salam A, Rahimi K, Perkovic V, Rodgers A. Effects of intensive blood pressure lowering on cardiovascular, and renal outcomes: updated systematic review, and meta-Analysis. Lancet. 2016; 387: 435-443. doi: 10.1016/S0140-6736(15)00805-3.
6. Rosendorff C, Lackland DT, Allison M, Aronow WS, Black HR, Blumenthal RS, Cannon CP, de Lemos JA, Elliott WJ, Findeiss L, Gersh BJ, Gore JM, Levy D, Long JB, O Connor CM, O Gara PT, Ogedegbe G, Oparil S, White WB. American Heart Association, American College of Cardiology, and American Society of Hypertension. Treatment of hypertension in patients with coronary artery disease: a scientific statement from the American Heart Association, American College of Cardiology, and American Society of Hypertension. Circulation. 2015; 131: e435-e470. doi: 10.1161/CIR.0000000000000207.
7. Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, Das SR, de Ferranti S, Després JP, Fullerton HJ, Howard VJ, Huffman MD, Isasi CR, Jiménez MC, Judd SE, Kissela BM, Lichtman JH, Lisabeth LD, Liu S, Mackey RH, Magid DJ, McGuire DK, Mohler ER, Moy CS, Muntner P, Mussolino ME, Nasir K, Neumar RW, Nichol G, Palaniappan L, Pandey DK, Reeves MJ, Rodriguez CJ, Rosamond W, Sorlie PD, Stein J, Towfighi A, Turan TN, Virani SS, Woo D, Yeh RW, Turner MB. Heart disease, and stroke statistics-2016 update: a report from the American Heart Association. Circulation. 2016; 133: e38-e360.
8. Nkomo VT, Gardin JM, Skelton TN, Gottdiener JS, Scott CG, Enriquez-Sarano M. Burden of valvular heart diseases: a population-based study. Lancet. 2006; 368: 1005-1011. doi: 10.1016/.S0140-6736(06)69208-8.
9. Rossebø AB, Pederesen TR, Borman K, Brudi P, Chambers JB, Egstrup K, Gerdts E, Gohlke-Bärwolf C, Holme I, Kesäniemi A, Malbecq W, Nienaber CA, Ray S, Skjarpe T, Wachtell K, Willenheimer R. Intensive lipid lowering with simvastatin, and ezetimibe in aortic stenosis. N Engl J Med. 2008; 359: 1343-1356.
10. Rieck AE, Cramartuc D, Borman K, Cramariuc D, Boman K, Gohlke-Bärwolf C, Staal EM, Lønnebakken MT, Rossebø AB, Gerdtset E. Hyperension in aortic stenosis: implications for left ventricular structure, and cardiovascular events. Hypertension. 2012; 60: 90-97.
11. Nielsen OW, Sajadieh A, Sabbah M, Greve AM, Olsen MH, Boman K, Nienaber CA, Kesäniemi YA, Pedersen TR, Willenheimer R, Wachtell K. Assessing optimal blood pressure in patients with asymptomatic aortic valve stenosis: the Simvastatin Ezetimibe in Aortic Stenosis Study (SEAS). Circulation. 2016: 134: 455-468. doi: 10.1161/CIRCULATIONAHA. 115.021213.
12. Bangalore S, Qin J, Sloan S, Murphy SA, Cannon CP. PROVE ITTIMI 22 Trial Investigators. What is the optimal blood pressure in patients after acute coronary syndromes? Relationship of blood pressure, and cardiovascular events in the PRavastatin OR atorVastatin Evaluation, and Infection Therapy-Thrombolysis In Myocardial Infarction (PROVE IT-TIMI) 22 trial. Circulation. 2010; 122: 2142-2151. doi: 10.1161/CIRCULATIONAHA.109.905687.
13. Bakris GL, Gaxiola E, Messerli FH, Mancia G, Erdine S, Cooper-DeHoff R, Pepine CJ. INVEST Investigators. Clinical outcomes in the diabetes cohort of the INterNational VErapamil SR-Trandolapril study. Hypertension. 2004; 44: 637-642. doi: 10.1161/01. HYP.0000143851.23721.26.
14. Otto CM, Lind BK, Kitzman DW, Gersh BJ, Siscovick DS. Association of aortic-valve sclerosis with cardiovascular mortality, and morbidity in the elderly. N Engl J Med. 1999; 341: 142-147. doi: 10.1056/NEJM199907153410302.
15. Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC), and the European Association for Cardiothoracic Surgery (EACTS). Guidelines for the management of valvular heart disease (version 2012). Eur Heart J. 2012; 33: 2452-2496.
16. Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP 3rd, Guyton RA, O Gara PT, Ruiz CE, Skubas NJ, Sorajja P, Sundt TM 3rd, Thomas JD. American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014; 129: e521-e643. doi: 10.1161/CIR.0000000000000031.